Prognostic factors in traumatic optic neuropathy patients in KhonKaen Hospital
Keywords:
Traumatic optic neuropathy, prognostic factorsAbstract
Objective : To investigate the prognostic factors and related demographic data that influence the visual outcome in traumatic optic neuropathy patients at KhonKaen Hospital
Methods : Sixty-two cases of traumatic optic neuropathy patients presented at KhonKaen Hospital between 2010-2020 were examined retrospectively. Clinical data of the patients, including Initial visual acuity (Initial VA), final visual acuity (Final VA), associated injury, CT images and treatments, were collected. The patients were divided in 2 groups based on the result of the final VA when compared to the initial VA. Statistical analysis were performed to identify associated factors with the visual outcome.
Result : Most of the patients were male (n=53, 84.13%). Ages were in between 12-67 years old. The most common cause of disease was motorcycle accident (79.37%). Most common associated injury was head injury (90.48%). Eighty-eight percent of the patients had initial VA worse than 3/60. At the end of the treatment, most of the patients had final VA worse than 3/60 (71.42%). The initial VA better than 3/60 was a good prognostic factor that determine the better visual outcome (p-value = 0.036). Treatments with or without systemic corticosteroids were not statistical different in the study.
Traumatic optic neuropathy had poor visual prognosis. The good initial VA was good prognosis factor. Prevention of accident and the decreasing of accidental severity were recommended.
References
Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology 1999; 106(7): 1268-77.
World Health Organization. ICD-11 for mortality and morbidity statistics. Version: 2019 April. Geneva: WHO; 2019 [cited 2019 Aug 20]. Available from: https://icd.who.int/browse11/l-m/en.
Steinsapir, K.D., Goldberg, R.A. Traumatic optic neuropathy: a critical update. Comp Ophthalmol Update 2005; 6: 11–21.
Entezari M, Rajavi Z, Sedighi N, Daftarian N, Sanagoo M. High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. Graefes Arch ClinExpOphthalmol 2007; 245(9): 1267-71.
Yu-Wai-Man_P, Gri_iths_PG. Steroids for traumatic optic neuropathy. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD006032.
Yu Wai Man P, Griffiths PG. Surgery for traumatic optic neuropathy. Cochrane Database Syst Rev 2005; (4): CD005024.
ศูนย์เทคโนโลยีสารสนเทศการขนส่งและจราจร สำนักงานนโยบายและแผนการขนส่งและจราจร (สนข.) [อินเทอร์เน็ต]. 2557 [เข้าถึงเมื่อ 20 เมษายน 2564]. เข้าถึงได้จาก http://mistran.otp.go.th/ReportService/VehicleRegistrationAll.aspx.
Wen-Guei Yang, Chien-Tzung Chen, Pei-Kwei Tsay. Outcome for Traumatic Optic Neuropathy - Surgical Versus Nonsurgical Treatment. Annals of Plastic Surgery 2004; 52: 36-42
Ulrich S, Helmut W, William H. Clinical Neuro-Ophthalmology A Practical Guide : chapter 3 Functional Anatomy of the Human Visual Pathway. Springer Berlin Heidelberg New York ,2007
A Carta, L Ferrigno, M Salvo, S Bianchi-Marzoli, A Boschi, F Carta. Visual prognosis after indirect traumatic optic neuropathy. J Neurol Neurosurg Psychiatry 2003; 74: 246–248
Hall ED. The neuroprotective pharmacology of methylprednisolone. Journal of Neurosurgery 1992; 76(1): 13-22.
Wanicha C., Niphon C. A prospective randomized trial of megadose methylprednisolone and high dose dexamethasone for traumatic optic neuropathy. J Med Assoc Thai 2002; 85(5): 597-603.
Downloads
Published
How to Cite
Issue
Section
License
วารสารนี้เป็นลิขสิทธิ์ของโรงพยาบาลมหาสารคาม